Stay updated on Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page. No changes to study content or user-facing information.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision note updated: added Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page shows a minor system revision update from v3.4.1 to v3.4.2, with no changes to the study information, eligibility criteria, or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1. This appears to be a minor version update with no changes to the study details or content.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded the glossary display and updated QC metadata to show Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while removing the older Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. No substantive study details or user-facing features appear affected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Acral Lentiginous Melanoma Clinical Trial page.